Article History
Received: 13 April 2022
Accepted: 4 June 2022
First Online: 10 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: S. G. received travel grants and honorary from Allergen, Novartis, Teva, and Ely Lilly. C. B. received travel grants and honorary from Allergen, Novartis, Teva, and Ely Lilly. L. P. is the Chief Scientific Officer of EDRA-LSWR Publishing Company and of Inpeco SA Total Lab Automation Company. In the last year, he has been a scientific consultant to AbbVie, USA; BCG, Switzerland; Boehringer-Ingelheim, Germany; Compass Pathways, UK; Johnson & Johnson, USA; Takeda, USA; VeraSci, USA; Vifor, Switzerland.